SciBite, an analytics company, announced a strategic partnership with ChemAxon, the leading cheminformatics company, enabling Pharmaceutical companies to capitalise on unlocking the wealth of R&D data that is at their disposal.
SciBite's platform is the culmination of decades of experience in applying semantic analytics to unstructured data. At its core are established controlled vocabularies which apply an explicit, unique meaning to scientific terms, enabling complex text to be contextualised and used as high quality, actionable data, irrespective of its source.
This partnership will bring deeper chemistry awareness to the SciBite platform. A seamless integration of ChemAxon's chemical recognition capabilities will enable customers to quickly and accurately extract structures from images and chemical names within scientific documents.
To extract and search a combination of chemistry and biology knowledge via a single interface and a consistent application programming interface, allows users to answer questions such as "What research has been conducted in a given disease and/or target related to a specific chemical substructure?"
ChemAxon will also integrate SciBite's unique semantic technology to deliver biology intelligence within its suite of applications, including ChemLocator.
"Our partnership with ChemAxon will bridge the gap between chemistry and biology and deliver unparalleled insights. ChemAxon and SciBite share a similar philosophy, providing customers with interoperable, best of breed solutions to further power their next generation analytics," said Rob Greenwood, CEO of SciBite.
"We're conscious of the great potential in better exploitation of scientific data and are delighted to simplify evidence based decision working with SciBite the domain expert of semantic entity recognition," said Ferenc Csizmadia, ChemAxon CEO.
(Source: SciBite)